Diagnosis, Diagnostics, Immunodiagnosis & Immunodiagnostics:

10353.  Balasubramanian S, Anandnathan K, Shivbalan S, Datta M, Amalraj E. Cut-off  ematocrit value for hemoconcentration in dengue hemorrhagic fever. J Trop Pediatr. 2004 Apr;50(2):123-4.

10354.  Jessie K, Fong MY, Devi S, Lam SK, Wong KT. Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis. 2004 Apr 15;189(8):1411-8.

              Pathogenesis:

10355.  Ashburn PM, Craig CF; US Army Board for the Study of Tropical Diseases. Experimental investigations regarding the etiology of dengue fever. 1907. J Infect Dis. 2004 May 1;189(9):1747-83; discussion 1744-6.

10356.  Das P. Infectious disease surveillance update. Lancet Infect Dis. 2004 May;4(5):259.

10357.  Liew KJ, Chow VT. Differential display RT-PCR analysis of ECV304 endothelial-like cells infected with dengue virus type 2 reveals messenger RNA expression profiles of multiple human genes involved in known and novel roles. J Med Virol. 2004 Apr;72(4):597-609.

              Vaccines:

10358.  Rothman AL. Dengue: defining protective versus pathologic immunity. J Clin Invest. 2004 Apr;113(7):946-51. Review.

10359.  Wu JJ, Huang DB, Pang KR, Tyring SK. Vaccines and immunotherapies for the prevention of infectious diseases having cutaneous manifestations. J Am Acad Dermatol. 2004 Apr;50(4):495-528; quiz 529-32. Review.

              Therapy:

10360.  Men R, Yamashiro T, Goncalvez AP, Wernly C, Schofield DJ, Emerson SU, Purcell RH, Lai CJ.  Identification of chimpanzee Fab fragments by repertoire cloning and production of a full-length humanized immunoglobulin G1 antibody that is highly efficient for neutralization of dengue type 4 virus. J Virol. 2004 May;78(9):4665-74.

10361.  O'Hanlon LH. Tinkering with genes to fight insect-borne disease. Researchers create genetically modified bugs to fight malaria, Chagas, and other diseases. Lancet. 2004 Apr 17;363(9417):1288-9.